Nicholas Ellis @ www.Youtube.com "Metastasis accounts for most of cancer's lethality," said Sherwood, who is an assistant professor of biology at Duke. "It's the most...
Novocure TTF was FDA approved in April 2011 for recurrent Glioblastoma Multiforme. This is an older video that explains how it works. For more details...
The Novocure executive director presents tumor treating fields (TTF) therapy, which uses electric fields to kill procreating cancer cells, shrinking tumors or slowing growth with...
The Novocure exec answers questions about his company's new electric field therapy that targets procreating cancer cells, slowing or reversing tumor growth.
